Abstract. Objective To detect the changes of anterior gradient-2 (AGR2) level before and after operation in tissue and serum of patients with cervical intraepithelial neoplasia (CIN) and cervical cancer, and to explore its clinical significance. Methods the serum and tissue of patients with cervical cancer (n=30) and patients with CIN (n=20) before and after operation were collected. Serum sample from 20 health women and cervix tissue samples of 20 patients undertaken total hysterectomy due to myoma were collected for the control group. AGR2 levels were detected by enzyme-linked immunosorbent assay (ELISA). Results the levels of AGR2 in preoperative serum and tissues of cervical cancer were significantly higher than that of CIN and normal control group (all P<0.01); the levels of serum AGR2 after operation in the cervical cancer and CIN patients were significantly lower than that of preoperative (all P<0.01); the AGR2 levels of serum and tissue of cervical cancer patients were significantly different for the tumor size, FIGO stages and lymph node involvement (P<0.01 or 0.05); Pearson analysis showed that serum AGR2 levels before operation positively correlated to that after operation in the patients with CIN and cervical cancer (r=0.747, P=0.000); the levels of serum AGR2 before and after operation positively correlated to that in cervical tissue (r=0.789, P=0.000; r=0.700, P=0.000). Conclusion the levels of AGR2 in serum and tissue of cervical cancer increased obviously, which closely related to tumor size, FIGO stages and lymph node involvement. It is valuable to detect the level of AGR2 for judging the surgical curative effect of patients with cervical cancer.
Introduction
Cervical cancer is one of the most common gynecological malignancies. In China, the incidence of cervical cancer is12.96/10 000, the mortality rate is 3.28/10 000, and the incidence and mortality of cervical cancer increase with age. [1] With the development of molecular biology, a number of serological indicators related to tumor prognosis have been paid more and more attention. The anterior gradient-2(AGR2) is the homologous gene of the Xenopus AGR2 from the cDNA Library of the breast cancer cell line MCF7. [2] Over expression of AGR2 in multiple malignancies is closely related to the occurrence and development of tumors. It is a potential marker gene for early diagnosis and prognosis. [3] At present, the clinical significance of AGR2 in cervical cancer is not clear, and the related reports are rare. In this study, we detected the changes of serum and pathological AGR2 levels in cervical cancer patients before and after operation, and analyzed the relationship between them and the clinicopathological characteristics of cervical cancer, so as to provide some evidences for AGR2 aided diagnosis of cervical cancer, curative effect and prognosis.
Materials and Methods

General Information
This study was approved by our hospital ethics committee, and patients signed an informed consent form 30 patients with cervical cancer and 20 cases of CIN patients who were diagnosed in China-Japan Union Hospital of Jilin University from June 2014 to June 2017. Inclusion criteria: (1) primary cervical cancer diagnosed by pathology for the first time; (2) no preoperative systemic chemotherapy and other adjuvant antitumor therapy, no other systemic tumor history. (3) All patients are informed and volunteered. In cervical cancer group, the age was 51-67 years old, the median age was (52.7±8.3) years old, there were 19 cases of stage I, 11 cases of stage II. Confirmed by pathological examination, using FIGO staging. The degree of differentiation: 4 cases of high differentiation, 15 cases of middle differentiation, 11 cases of low differentiation, lymph node metastasis, 4 cases with lymph node metastasis, and 26 cases without lymph node metastasis. The CIN group was 43~64 years old, and the median age was (50.4±5.8) years. There were 7 cases of stage II, 13 cases of stage III, confirmed by pathological examination, using FIGO staging. The specimens of 20 healthy women in our hospital and 20 normal cervix specimens with hysterectomy for hysteromyoma were collected as the normal control group.
Methods
Detection of AGR2 level in Serum and Tissue. In the patients with cervical cancer and CIN, 3mL fasting venous blood was collected in the morning before and 1 week after the operation. The samples were placed in centrifuge, 3000r/min, centrifuge for 10min, kept the serum in the refrigerator at -80 C. The resected fresh cervical lesions were washed and put into the precooled plastic bottle and then put it into the liquid nitrogen. Then the specimens were crushed by a precooled pulverizer. The 100mg specimens were weighed and weighed into the homogenate buffer test tube. The homogenate was made at 4 C, 5000r/min and 15min centrifugally, and was placed in -80 C refrigerator for preservation. AGR2 ELISA kit was purchased from Beijing Yi Ke panbo Biological Technology Co., Ltd., and the AGR2 level was determined by enzyme linked immunosorbent assay (ELISA), and strictly operated according to the instructions of the kit.
Statistical Methods. All data using SPSS 21.0 statistical software for processing, measurement data using mean and standard deviation (X±S) to represent. And paired t test for data comparation between two groups, single factor analysis of variance was used in multiple groups, Each two groups was compared by LSD, and Pearson was used in correlation analysis. P <0.05 considered statistically significant.
Result
Comparison of the levels of AGR2 in the Serum and Tissues of Cervical Cancer and CIN Patients before and after Operation
The levels of AGR2 in the preoperative serum and tissues of cervical cancer was significantly higher than that of CIN group and control group (P<0.01); The levels of AGR2 in the preoperative serum of CIN group is slightly higher than the normal control group, no significant difference (P>0.05); the level of AGR2 in CIN group was slightly higher than that in control group, and there was no statistical difference (P>0.05). The level of post-operative serum AGR2 in cervical cancer group and CIN group was significantly lower than that before operation (P<0.01), (Figure 1 and 2) . 
The Relationship between the Level of Serum AGR2 and the Tissue of Cervical Cancer
Correlation analysis showed that preoperative serum AGR2 levels in cervical cancer group and CIN group were positively correlated with that after operation (r=0.747, P=0.000), preoperative tissue AGR2 levels in cervical cancer group and CIN group were positively correlated with that after operation(r=0.789, P=0.000; r=0.700, P=0.000), (Figure 3 
Discussion
The level of related serum markers before and after operation can provide a certain reference value for the early diagnosis, evaluation of the curative effect and the prognosis of the tumor. Previous studies have confirmed that AGR2 is overexpressed in lung cancer, breast cancer, pancreatic cancer and other diseases, and is closely related to the formation and metastasis of tumor [2] . Pohler et al. [4] have confirmed that AGR2 inhibits P53 phosphorylation and its activity, the cells lose normal control and lead to cancer. Wang Weiwei et al. [5] have found that double nitropiperazine (DNP) is involved in the invasion and metastasis of nasopharyngeal carcinoma cells by increasing the expression of AGR2 at the transcriptional level. Li Yuejin et al. [6] show that AGR2 is highly expressed in nasopharyngeal carcinoma cell line 5-8F. Interference with AGR2 can significantly reduce the migration and invasion function of cancer cells, and decrease its tumorigenic ability in vitro. The removal of AGR2 gene in a special way by RNAi technique can significantly reduce the metastasis of in lung cancer cells. [7] It can be seen that the increase of AGR2 can promote the proliferation, invasion and metastasis of tumor cells. Therefore, AGR2 is a potential biomarker for the diagnosis, efficacy and prognosis of tumor. At present, the expression of AGR2 in cervical cancer is not clear, and the related literature is rarely reported.
This study explored the role of AGR2 in the development of cervical cancer, the levels of AGR2 in preoperative serum and tissues of cervical cancer were significantly higher than that of CIN and normal control group ; the levels of serum AGR2 after operation in the cervical cancer and CIN patients were significantly lower than that of preoperative ; the AGR2 levels of serum and tissue of cervical cancer patients were significantly different for the tumor size, FIGO stages and lymph node involvement ; Pearson analysis showed that serum AGR2 levels before operation positively correlated to that after operation in the patients with CIN and cervical cancer ; the levels of serum AGR2 before and after operation positively correlated to that in cervical tissue , so that the postoperative serum AGR2 level decreased in tumor tissue after resection and may reduce the AGR2 secreted into the blood, in to a certain extent, can be used as a reference index to estimate the curative effect of operation.
This study analyzed the relationship between AGR2 level and clinicopathological characteristics in serum and cervical cancer tissues. The results showed that AGR2 levels in serum and tissues of cervical cancer were related to tumor size, FIGO staging and lymph node metastasis, which were not related to age, pathological type and differentiation. It shows that AGR2 has a close relationship with the invasion and metastasis of malignant tumor. Zhang et al. [8] found that AGR2 was significantly related to the size, depth of invasion and TNM staging of gastric cancer. Bai Xiaoying et al. [9] found that epithelial ovarian cancer and ovarian cancer serum AGR2 level, the expression of AGR2 protein was significantly higher than that of benign ovarian tumor and healthy people, the positive expression of AGR2 in epithelial ovarian cancer serum AGR2 levels and cancer rates with clinical stage and lymph node metastasis. Liu Lina et al. [10] found that in colorectal cancer AGR2 positive expression rate was significantly higher in normal tissues, the positive expression rate and the degree of tumor differentiation and lymph node metastasis of AGR2 was significantly related to the development process of AGR2 in colorectal carcinogenesis and play an important role. The above studies have shown that AGR2 levels are involved in the invasion and metastasis of different tumors.
In summary, cervical cancer patients with elevated serum AGR2, associated with tumor size, FIGO stage, lymph node metastasis in cervical cancer, invasion and metastasis, in the curative effect judgment provides a certain reference value, but also provides a new target for tumor therapy. The future work will expand the sample size. Meanwhile, we will further follow up the operative patients, understand the relationship between AGR2 and postoperative survival time, and clarify the relationship between AGR2 and prognosis of cervical cancer.
